About David Kabakoff
Form D filings for RareCyte from 2019 to 2023 list David Kabakoff as director.
David Kabakoff first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name David Kabakoff in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Kabakoff works with at each company, as listed on that company's latest Form D.
RareCyte, Inc. · Form D, Jul 25, 2023
RS
Ronald Seubert
Director
Robert Weisskoff
Director
DM
Daniel Marshak
Director
JG
Jan Garfinkle
Director
AS
Andrew Schwab
Director
SR
Stephen Reichenbach
Executive officer
JJ
Joseph Victor Jr.
Chief Executive Officer and director